Improved Autism Care Linked to Coordinated Caregiver Training, Says ACES
Team-Based Caregiver Training Linked to Improved Autism Outcomes, ACES Study Finds Children with autism spectrum disorder (ASD) experience significantly better developmental outcomes when their caregivers participate in structured, team-based training programs, according to a new report from ACES 2020, LLC…
Digital Assistant Tools Enhance Primary Care Outcomes in Congestive Heart Failure Patients
Counterpart Assistant Technology Linked to Improved Heart Failure Management and Reduced Hospitalizations, New Whitepaper Finds Counterpart Health, Inc. (“Counterpart”),Digital a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV), has unveiled compelling new research linking the use of its…
PureHealth Achieves AED 505M Net Profit and AED 1.1B EBITDA in Q1 2025
PureHealth Reports AED 505 Million Net Profit and AED 1.1 Billion EBITDA for Q1 2025, Signaling Strong Start to the Year PureHealth Holding PJSC (ADX: PUREHEALTH), the largest integrated healthcare platform in the Middle East, has announced robust financial results…
Chemist Warehouse Rolls Out Enhanced In-Store Payment Option
Chemist Warehouse Revolutionizes In-Store Payments with Launch of NAB’s Pay by Bank and ShopBack Integration Chemist Warehouse, one of Australia’s largest pharmacy retailers, is once again leading the charge in customer-centric innovation by introducing a new in-store payment option that…
Seven Ardent Hospitals Recognized with ‘A’ Grades for Excellence in Patient Safety
Seven Ardent Health Hospitals Earn Top ‘A’ Safety Grade from The Leapfrog Group for Spring 2025 Ardent Health (NYSE: ARDT), a premier provider of healthcare services in rapidly growing mid-sized urban markets across the United States, announced today that seven…
Claritev Names Jason Kap to Board of Directors
Claritev Appoints Technology Executive Jason Kap to Board of Directors, Bolstering Strategy to Transform Healthcare with Innovation and Insight Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a leading technology, data, and insights company focused on advancing affordability, transparency, and…
Andlauer Healthcare Group Posts First Quarter 2025 Earnings
Andlauer Healthcare Group Reports Q1 2025 Financial Results and Announces UPS Acquisition Andlauer Healthcare Group Inc. (TSX: AND) (“AHG” or the “Company”) has released its financial results for the first quarter ended March 31, 2025, and announced a definitive agreement…
Healthcare Realty Releases Q1 2025 Earnings and Declares Dividend
Healthcare Realty Reports First Quarter 2025 Financial Results and Declares Quarterly Dividend of $0.31 Per Share Healthcare Realty Trust Incorporated (NYSE: HR), a leading real estate investment trust (REIT) focused on owning, operating, and developing high-quality outpatient medical facilities across…
Baxter Posts Q1 2025 Financial Performance
Baxter International Reports First-Quarter 2025 Results, Driven by Strategic Focus and Solid Operational Execution Baxter International Inc. (NYSE: BAX), a global leader in medical technology, today announced its financial results for the first quarter of 2025. The results reflect continued…
Cencora Foundation Event Tackles Inequities in Healthcare Access
Cencora Impact Foundation Conference Champions Global Collaboration to Dismantle Barriers to Healthcare Access The Cencora Impact Foundation, a philanthropic arm of Cencora and an independent not-for-profit charitable organization, recently hosted its sixth annual Nonprofit Partner Conference, reinforcing its deep commitment…
Oklahoma Complete Health Unveils Enhanced 2025 Benefits for SoonerSelect Members
Oklahoma Complete Health Unveils New and Expanded SoonerSelect Benefits to Improve Member Health and Well-Being in 2025 Oklahoma Complete Health is introducing a comprehensive set of new and upgraded benefits for its SoonerSelect members in 2025, continuing its mission to…
Genmab to File sBLA with FDA for Epcoritamab in Combination with R2 Regimen for Relapsed/Refractory Follicular Lymphoma
Genmab to Submit sBLA to FDA for Epcoritamab in Combination with Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma Genmab A/S (Nasdaq: GMAB) has announced its plan to submit a supplemental Biologics License Application (sBLA) to the U.S. Food…